1. Liu, Weiren, Wang, Huqiang, Zhao, Qianfu, Yang, Dong, Shi, Yinghong. 2023. Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma. In Cancer communications (London, England), 44, 226-250. doi:10.1002/cac2.12513. https://pubmed.ncbi.nlm.nih.gov/38143235/
2. Li, Jie, Pan, Chaoyun, Boese, Austin C, Jin, Lingtao, Kang, Sumin. 2020. DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN-WEE1 Signaling. In Clinical cancer research : an official journal of the American Association for Cancer Research, 26, 3843-3855. doi:10.1158/1078-0432.CCR-19-3790. https://pubmed.ncbi.nlm.nih.gov/32341033/
3. Gravina, Teresa, Boggio, Chiara Maria Teresa, Gorla, Elisa, Corà, Davide, Baldanzi, Gianluca. 2023. Role of Diacylglycerol Kinases in Acute Myeloid Leukemia. In Biomedicines, 11, . doi:10.3390/biomedicines11071877. https://pubmed.ncbi.nlm.nih.gov/37509516/
4. Kelly, Elizabeth, Sharma, Devdutt, Wilkinson, Christopher J, Williams, Robin S B. 2018. Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in Dictyostelium discoideum. In Disease models & mechanisms, 11, . doi:10.1242/dmm.035600. https://pubmed.ncbi.nlm.nih.gov/30135067/
5. Zhou, Dong, Liu, Tao, Rao, Xinrui, Wang, Jian, Wu, Gang. 2023. Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3. In Thoracic cancer, 14, 1179-1191. doi:10.1111/1759-7714.14851. https://pubmed.ncbi.nlm.nih.gov/36965165/
6. Millings, Elizabeth J, De Rosa, Maria Caterina, Fleet, Sarah, Fischer, Stuart G, Leibel, Rudolph L. 2018. ILDR2 has a negligible role in hepatic steatosis. In PloS one, 13, e0197548. doi:10.1371/journal.pone.0197548. https://pubmed.ncbi.nlm.nih.gov/29847571/
智鼠故事 
